MVC COVID-19 Vaccine

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameMVC COVID-19 Vaccine
Drug Alias Name高端新冠肺炎疫苗MVC COVID-19 VaccineMVC-COV1901
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryVietnamTaiwanThailand +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesDynavax Technologies CorpMedigen Vaccine Biologics Corp
China Registration ClassN/A

Develop Information

Active CompaniesMedigen Vaccine Biologics Corp
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsInfections

Other Information

ATC CodeN/A
Related LinksN/A